New vaccine for allergies could be available soon
For millions of people who suffer from allergies, the summer can be a miserable time of year however a new vaccine designed could be on our shelves within the next four years. Over 10 million British people suffer from a number of allergies, including hay fever, asthma, eczema and reactions to cat fur and dust could benefit from a single vaccine that has been developed by Swiss researchers.
Experts say the jab would be the ‘holy grail’ of vaccines due to its ability to protect against multiple allergies, making it cost effective, easy to manufacture and administer. The scientists behind the pioneering vaccine from Cytos Biotechnology found that a course of the vaccine was almost as good as steroids at keeping asthma under control.
In recent trials conducted 63 asthmatics were given a course of the dummy drug for two to three months, asthma attacks and symptoms were cut by a third, they also found that one injection a week, for six weeks, cut reactions to house dust mites, runny noses and weepy eyes, by nearly 39%. Experts believe the jab in future could also have the potential to help people with allergies to shellfish and peanuts.
The vaccine which is formed of synthetic DNA similar to those found in the bug that causes tuberculosis is known as CYT003-QbG10, it tricks the body into thinking it is under attack from a dangerous bug, prompting a multi-pronged response.
A spokesman for Allergy UK said: ‘It does sound a very promising treatment, giving hope for those with severe asthma or allergy symptoms for whom the usual treatments aren’t enough, but there is still a long way to go before it will be available.
